Pfizer Stock News

CDC recommendation comes amid increasing fears the new Omicron variant will lead to surge in infections in the US.

COVID-19 testing is performed for two individuals at the Mount Olympus Senior Center parking lot in Millcreek on Tuesday, Oct. 5, 2021. A new study in Japan found that the omicron variant of the coronavirus is 4.2 times more contagious in its early stages than the delta variant, per Barron’s. | Jeffrey D. Allred, Deseret News A study in Japan found that the omicron variant is 4.2 times more contagious in the early stages than the delta variant A new study in Japan found that the omicron variant of the coronavirus is 4.2 times more contagious in its early stages than the delta variant, per Barron’s . “The Omicron variant transmits more, and escapes immunity built naturally and through vaccines more,” said Hiroshi Nishiura, professor of health and environmental sciences at Kyoto University who conducted the study, the report added. The study used genome data from the Gauteng province in South Africa. Currently, the study hasn’t been peer-reviews or published in a scientific journal. On Wednesday, World Health Organization officials said that preliminary data points to high transmission rates with minor cases, still rapidly spreading across the globe, according to Economic Times .

Oil Crude prices and US stocks appear to be in lock-step ahead of Fridays inflation data. Omicron uncertainty and concerns of weakening crude demand snapped a three-day rally in oil prices. Information on Omicron has been fluid, with earlier in the week one study showed a third Pfizer dose neutralized the Omicron variant. The latest []

Pfizer CEO Albert Bourla. Steven Ferdman/Getty Images Pfizer CEO Albert Bourla said that a fourth dose of the company''s COVID-19 vaccine may be needed amid Omicron fears. "I

About 2.6 million U.S. teens in this age group would be eligible for boosters already -- a small addition to the 141 million adults already eligible for boosters.

First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age and older. The booster dose is to be administered at least six months after completion of the primary series and is the same formulation and dosage strength as the doses in the primary se

Pfizer CEO Albert Bourla believes the omicron variant may prompt the necessity for a fourth COVID vaccine shot sooner than originally thought. Bourla made the comments in an interview with CNBC. “When we see real-world data, will determine if the omicron is well covered by the third dose and for how long,” he said. “And […] The post Pfizer CEO Says People Will Need Fourth COVID Vaccine Shot appeared first on The Political Insider .

The US and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination.

Fauci: Definition Of ''Fully Vaccinated'' Will Be Changed Authored by Zachary Stieber via The Epoch Times, The definition of fully vaccinated in the United States will be changed, Dr. Anthony Fauci said Wednesday. “It’s going to be a matter of when, not if,” Fauci, the head of the National Institute of Allergy and Infectious Diseases, said during an appearance on CNN. The term fully vaccinated presently refers to a person who receives two doses of the Pfizer or Moderna COVID-19 vaccines or the single-shot Johnson & Johnson jab. Fauci previously said the definition could be changed. Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention (CDC)—which set the definition—has left open the possibility of changing it. The definition is used by authorities imposing vaccine mandates across the country , including the federal mandates against healthcare workers and government contractors. Several of those mandates have been blocked in courts for now due to worries they’re illegal.

The decision comes as the delta and omicron coronavirus variants spread in the U.S.

The FDA authorized the Pfizer COVID-19 booster shot for all adults in the United States in November.

This expounded Advanced Renal Cell Carcinoma Therapeutics market report is presently delivered into its data which is dependent on a broad investigation of the market. Information about the forthcoming business sector drifts just as the current situation of the market

Pharmacy chain Dis-Chem Group has welcomed President Cyril Ramaphosas call to consider mandatory vaccinations for Covid-19 in workspaces. The company notified employees of its strategy to make Covid-19 vaccinations mandatory, a requirement which will be initiated from February 1, 2022. We are first and foremost an organisation that operates in the healthcare sector, and it is critical that we embody care, a focus on the wellbeing of all, and care for life. Also, a large proportion of our employees interact directly with the public, said the company. According to Dis-Chem, employees who are not fully vaccinated by the set date will be required to provide negative Antigen tests every Monday, and wear masks at all times. Both of these will be at the employees cost. If either of these are not complied with, disciplinary action will be taken. Dis-Chem urged workers who have not been vaccinated to do so within the given time period. Those who still need to receive their second Pfizer shot were encouraged to finalise their vaccination process by January 31, 2022.